{"id":"W4401199280","doi":"10.1136/bmjopen-2023-083691","title":"Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias – pilot study protocol","year":2024,"lang":"en","type":"article","venue":"BMJ Open","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Public Health Ontario; University of Toronto; University Health Network","funders":"Third Health Programme; European Commission; Agios Pharmaceuticals","keywords":"Medicine; Protocol (science); Clinical trial; Pilot trial; Protocol design; Research design; Medical physics; Randomized controlled trial; Alternative medicine; Surgery; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01774661,0.002554341,0.003140118,0.0006456603,0.001539036,0.001729886,0.001585522,0.003334272,0.01927372],"category_scores_gemma":[0.01155983,0.001268203,0.002811383,0.0005686323,0.001452447,0.001437803,0.001227042,0.004530003,0.003956022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001462746,"about_ca_system_score_gemma":0.008366164,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006586227,"about_ca_topic_score_gemma":0.001929921,"domain_scores_codex":[0.9928726,0.005144367,0.0003911372,0.0004845082,0.0003989266,0.0007085106],"domain_scores_gemma":[0.9926122,0.001633604,0.001480799,0.0008327533,0.00116261,0.002278006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9092675,0.03405373,0.002019919,0.001884125,0.001229201,0.0001816681,0.0002091567,0.002661984,0.005339759,0.001932978,0.01053571,0.03068418],"study_design_scores_gemma":[0.814905,0.168783,0.002621933,0.000247028,0.0003962043,0.0000611485,0.00004845153,0.001094166,0.0008402338,0.001093255,0.009865034,0.0000444892],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.06382212,0.0005193806,0.00576061,0.001062387,0.0005423129,0.9209228,0.002972399,0.0002010885,0.004196998],"genre_scores_gemma":[0.05727905,0.0003318885,0.0104362,0.001265998,0.0002088001,0.9271982,0.001072505,0.0000214521,0.002185874],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01927372,"threshold_uncertainty_score":0.09385419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.341661158231077,"score_gpt":0.5316405115425945,"score_spread":0.1899793533115176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}